TG Therapeutics Inc (TGTX)
13.83
-0.16
(-1.14%)
USD |
NASDAQ |
Apr 19, 11:41
TG Therapeutics Free Cash Flow (Quarterly): -13.21M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.21M |
| September 30, 2023 | 83.70M |
| June 30, 2023 | -42.00M |
| March 31, 2023 | -59.90M |
| December 31, 2022 | -23.87M |
| September 30, 2022 | -34.50M |
| June 30, 2022 | -49.12M |
| March 31, 2022 | -68.70M |
| December 31, 2021 | -86.99M |
| September 30, 2021 | -67.28M |
| June 30, 2021 | -60.34M |
| March 31, 2021 | -81.42M |
| December 31, 2020 | -52.18M |
| September 30, 2020 | -56.62M |
| June 30, 2020 | -43.88M |
| March 31, 2020 | -62.18M |
| December 31, 2019 | -30.43M |
| September 30, 2019 | -33.27M |
| June 30, 2019 | -35.88M |
| March 31, 2019 | -33.36M |
| December 31, 2018 | -33.70M |
| September 30, 2018 | -33.04M |
| June 30, 2018 | -34.22M |
| March 31, 2018 | -28.07M |
| December 31, 2017 | -21.86M |
| Date | Value |
|---|---|
| September 30, 2017 | -22.78M |
| June 30, 2017 | -26.83M |
| March 31, 2017 | -22.30M |
| December 31, 2016 | -17.04M |
| September 30, 2016 | -15.06M |
| June 30, 2016 | -12.88M |
| March 31, 2016 | -16.96M |
| December 31, 2015 | -12.88M |
| September 30, 2015 | -10.70M |
| June 30, 2015 | -12.26M |
| March 31, 2015 | -8.889M |
| December 31, 2014 | -15.12M |
| September 30, 2014 | -8.052M |
| June 30, 2014 | -3.573M |
| March 31, 2014 | -8.332M |
| December 31, 2013 | -4.826M |
| September 30, 2013 | -1.156M |
| June 30, 2013 | -2.558M |
| March 31, 2013 | -2.205M |
| December 31, 2012 | -0.8333M |
| September 30, 2012 | -2.993M |
| June 30, 2012 | -0.5012M |
| March 31, 2012 | -0.8616M |
| December 31, 2011 | -0.0565M |
| September 30, 2011 | -0.0301M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-86.99M
Minimum
Dec 2021
83.70M
Maximum
Sep 2023
-43.06M
Average
-49.12M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 1.727M |
| Geron Corp | -41.00M |
| Editas Medicine Inc | -23.55M |
| G1 Therapeutics Inc | -12.79M |
| Mersana Therapeutics Inc | -32.35M |